CervoMed Inc. (CRVO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, CervoMed Inc. reported revenue of $4.01M, down 58.9% from the prior year. The company ran a net loss, with a net margin of -673.1%. It held $22.88M in total assets against $4.66M in total liabilities.
Key ratios (FY2025)
-706.2%
Operating margin
-673.1%
Net margin
-148.0%
Return on equity
-58.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.01M | $9.74M | $7.14M | $0 | — | — | — | — | — | — |
| Operating Income | -$28.29M | -$18.23M | -$7.81M | -$3.48M | -$24.68M | -$15.97M | -$11.55M | -$18.96M | -$11.35M | -$18.37M |
| Net Income | -$26.97M | -$16.29M | -$2.17M | -$5.80M | -$24.10M | -$14.19M | -$11.80M | -$18.37M | -$1.36M | -$18.04M |
| EPS (Diluted) | $-2.98 | $-2.02 | $-0.82 | $-11.20 | $-12.38 | $-0.30 | $-1.76 | $-8.21 | $-3.16 | $-1.76 |
| Total Assets | $22.88M | $43.08M | $9.97M | $4.16M | $37.84M | $27.73M | $24.11M | $18.20M | $26.15M | $17.48M |
| Total Liabilities | $4.66M | $3.88M | $2.60M | $13.16M | $2.93M | $2.92M | $3.98M | $2.59M | $4.92M | $8.30M |
| Shareholders' Equity | $18.22M | $39.20M | $7.38M | -$33.29M | $34.91M | $24.81M | $20.13M | $15.61M | $21.23M | $9.18M |
| Cash & Equivalents | $8.24M | $9.00M | $7.79M | $4.09M | $37.31M | $18.52M | $14.18M | $7.99M | $8.90M | $1.55M |
| Operating Cash Flow | -$23.45M | -$16.53M | -$7.45M | -$2.57M | -$14.50M | -$13.55M | -$9.86M | -$10.77M | -$12.33M | -$10.77M |
| Capital Expenditures | — | — | — | — | — | — | — | — | $447.8K | $2.3K |
| Shares Outstanding | 9.25M | 8.70M | 5.67M | 518.1K | 2.04M | 64.02M | 33.48M | 3.38M | 968.0K | 10.35M |